Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Volcano888 who wrote (160)	2/2/1999 1:55:00 AM
From: Bengalus	Respond to of 5582

Here's the full cite for the second Godfrey article mentioned. Must have cut it off by accident. Altern Ther Health Med 1996 Nov;2(6):63-72 Zinc for treating the common cold: review of all clinical trials since 1984.

To: Volcano888 who wrote (160)	2/2/1999 2:03:00 AM
From: Bengalus	Read Replies (1) \| Respond to of 5582

Also, a patent search didn't turn up anything relevant for either Hensley or Davidson. While a patent on Zinullose might be pending, it seems reasonable that there might have been some prior patent granted for their "ionic free flow emulsification technology which led to their discovery of the compound Zinullose" as the Gel Tech website states. But that's apparently not the case. To conduct a patent search, go to www.uspto.gov